About: Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.60 (-4.41%)
ATOS NASDAQ Atossa Genetics Inc
Atossa Genetics Inc share price
Atividade de preço de ATOS
Último preço
$ 2,600
Variação (24h)
-0,12 USD (4,41%)
Volume
76.91K
Volume (média 4 sem.)
-
Abertura
$ 2,74
Variação do dia
$ 2,60 - $ 2,85
Fechamento anterior
$ 2,72
Último negócio
23 Oct, 8:00 pm GMT+0
Atrasado
23 Oct, 8:00 pm GMT+0
ATOS price performance
Atrasado
23 Oct, 8:00 pm GMT+0
quote.marketSignals